Learn More
Description
- Leading molecular point-of-care (POC) platform in the United States
- Trusted by hospitals, physician offices, and urgent care facilities nationwide
- Emergency Use Authorization (EUA) supports flexible near-patient testing environments
- Sample types tested direct or in viral transport media (VTM) include throat swabs, nasal swabs, and nasopharyngeal swabs
- Room temperature storage eliminates the need for refrigeration
- Assay kit includes 24 tests, sample collection swabs, pipettes, and control swabs
- Control kit is available for addition positive and negative swabs
Specifications
Specifications
| Certifications/Compliance | CLIA |
| Content And Storage | Ambient |
| Control Sets | 12 Positive and 12 Negative (Additional Controls Sold Separately) |
| CE Marker | Yes |
| Clia Complexity | Waived, Moderate, High |
| Detectable Analytes | COVID-19 |
| DoA Calibrators | No |
| Format | Kit |
| Sample Type | Nasal Swabs, Nasopharyngeal Swabs, and Throat Swabs |
| Sensitivity | See Package Insert |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.